{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:44:58Z","timestamp":1785577498306,"version":"3.56.0"},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.5551\/jat.61358","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T22:06:41Z","timestamp":1614377201000},"page":"482-491","source":"Crossref","is-referenced-by-count":11,"title":["Elevated Glycated Albumin in Serum Is Associated with Adverse Cardiac Outcomes in Patients with Acute Coronary Syndrome Who Underwent Revascularization Therapy"],"prefix":"10.5551","volume":"29","author":[{"given":"Jianwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengping","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH and Avezum A: Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med, 2009; 169: 402-409","DOI":"10.1001\/archinternmed.2008.572"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Cakmak M, Cakmak N, Cetemen S, Tanriverdi H, Enc Y, Teskin O and Kilic ID: The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol, 2008; 24: 375-378","DOI":"10.1016\/S0828-282X(08)70600-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes care, 2003; 26: 688-696","DOI":"10.2337\/diacare.26.3.688"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kurihara O, Takano M, Yamamoto M, Shirakabe A, Kimata N, Inami T, Kobayashi N, Munakata R, Murakami D, Inami S, Okamatsu K, Ohba T, Ibuki C, Hata N, Seino Y and Mizuno K: Impact of prediabetic status on coronary atherosclerosis: a multivessel angioscopic study. Diabetes care, 2013; 36: 729-733","DOI":"10.2337\/dc12-1635"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, Ceriello A, Rhee M, Phillips LS, Chung S, Cravalho C, Jagannathan R, Monnier L, Colette C, Owens D, Bianchi C, Del Prato S, Monteiro MP, Neves JS, Medina JL, Macedo MP, Ribeiro RT, Filipe Raposo J, Dorcely B, Ibrahim N and Buysschaert M: Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract, 2020; 165: 108233","DOI":"10.1016\/j.diabres.2020.108233"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Parrinello CM and Selvin E: Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep, 2014; 14: 548","DOI":"10.1007\/s11892-014-0548-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Koga M: Glycated albumin; clinical usefulness. Clin Chim Acta, 2014; 433: 96-104","DOI":"10.1016\/j.cca.2014.03.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M and Coresh J: Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol, 2014; 2: 279-288","DOI":"10.1016\/S2213-8587(13)70199-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M and Coresh J: Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death. Circulation, 2015; 132: 269-277","DOI":"10.1161\/CIRCULATIONAHA.115.015415"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Copur S, Siriopol D, Afsar B, Comert MC, Uzunkopru G, Sag AA, Ortiz A, Covic A, van Raalte DH, Cherney DZ, Rossing P and Kanbay M: Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker. Acta Diabetol, 2021; 58: 81-91","DOI":"10.1007\/s00592-020-01581-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA and White HD: Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 2018; 138: e618-e651","DOI":"10.1161\/CIR.0000000000000617"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Roohk HV, Zaidi AR and Patel D: Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation. Inflamm Res, 2018; 67: 21-30","DOI":"10.1007\/s00011-017-1089-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T and Kiyohara Y: Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol, 2015; 14: 84","DOI":"10.1186\/s12933-015-0247-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Shen J, Fang DH and Lou S: Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J, 2007; 71: 1067-1073","DOI":"10.1253\/circj.71.1067"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY and Shen WF: Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients. Cardiology, 2012; 123: 84-90","DOI":"10.1159\/000342055"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mihara A, Ohara T, Hata J, Honda T, Chen S, Sakata S, Oishi E, Hirakawa Y, Nakao T, Kitazono T and Ninomiya T: Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study. Atherosclerosis, 2020; 311: 52-59","DOI":"10.1016\/j.atherosclerosis.2020.08.016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kannel WB and McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes care, 1979; 2: 120-126","DOI":"10.2337\/diacare.2.2.120"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mehran R, Dangas GD, Kobayashi Y, Lansky AJ, Mintz GS, Aymong ED, Fahy M, Moses JW, Stone GW and Leon MB: Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol, 2004; 43: 1348-1354","DOI":"10.1016\/j.jacc.2003.04.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yang ZK, Shen Y, Shen WF, Pu LJ, Meng H, Zhang RY, Zhang Q, Chen QJ, De Caterina R and Lu L: Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease. Int J Cardiol, 2015; 197: 241-247","DOI":"10.1016\/j.ijcard.2015.06.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lu L, Jin Pu L, Chen QJ, Wang L, Peng W, Yan X, Zhang Q, Yan Zhang R, Gong PH, Qiu JP and Shen WF: Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clin Chim Acta, 2008; 396: 33-37","DOI":"10.1016\/j.cca.2008.06.019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Du R, Zhang RY, Lu L, Shen Y, Pu LJ, Zhu ZB, Zhang Q, Hu J, Yang ZK, Ding FH, Zhang JS and Shen WF: Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study. Cardiovasc Diabetol, 2018; 17: 149","DOI":"10.1186\/s12933-018-0792-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Shen Y, Lu L, Ding FH, Sun Z, Zhang RY, Zhang Q, Yang ZK, Hu J, Chen QJ and Shen WF: Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Cardiovasc Diabetol, 2013; 12: 165","DOI":"10.1186\/1475-2840-12-165"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y and Hori M: Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J, 2008; 55: 503-507","DOI":"10.1507\/endocrj.K07E-089"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hashimoto K, Tanikawa K, Nishikawa J, Chen Y, Suzuki T and Koga M: Association of variation range in glycated albumin (GA) with increase but not decrease in plasma glucose: implication for the mechanism by which GA reflects glycemic excursion. Clin Biochem, 2015; 48: 397-400","DOI":"10.1016\/j.clinbiochem.2014.12.021"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Newsholme P, Cruzat VF, Keane KN, Carlessi R and de Bittencourt PI, Jr.: Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J, 2016; 473: 4527-4550","DOI":"10.1042\/BCJ20160503C"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Oka S, Deyama J, Umetani K, Harama T, Shimizu T, Makino A, Sano K and Nakamura M: Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction. Cardiovasc Endocrinol Metab, 2018; 7: 47-53","DOI":"10.1097\/XCE.0000000000000145"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW and Zhou YJ: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions. Diabetol Metab Syndr, 2014; 6: 76","DOI":"10.1186\/1758-5996-6-76"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Pu Z, Lai L, Yang X, Wang Y, Dong P, Wang D, Xie Y and Han Z: Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis. Endocrine, 2020; 67: 526-534","DOI":"10.1007\/s12020-019-02150-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zhao X, Li Q, Tu C, Zeng Y and Ye Y: High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study. Cardiovasc Diabetol, 2020; 19: 171","DOI":"10.1186\/s12933-020-01146-w"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Morel O, El Ghannudi S, Hess S, Reydel A, Crimizade U, Jesel L, Radulescu B, Wiesel ML, Gachet C and Ohlmann P: The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight. Thromb Haemost, 2012; 108: 338-348","DOI":"10.1160\/TH11-12-0876"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Schoos MM, Dangas GD, Mehran R, Kirtane AJ, Yu J, Litherland C, Clemmensen P, Stuckey TD, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL, Jr., Maehara A and Stone GW: Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). Am J Cardiol, 2016; 117: 192-200","DOI":"10.1016\/j.amjcard.2015.10.037"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/4\/29_61358\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:43:20Z","timestamp":1648878200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/4\/29_61358\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.61358","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"61358"}}